Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$629M |
| 2 |
AGN
Allergan plc
AGN
|
+$463M |
| 3 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$350M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$315M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$978M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$675M |
| 3 |
Apple
AAPL
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$387M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.7% |
| 2 | Healthcare | 5.71% |
| 3 | Financials | 4.62% |
| 4 | Consumer Discretionary | 4.5% |
| 5 | Communication Services | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4301
CALL
NOV
NOV
$6.99B
| $418K | ﹤0.01% |
19,700
-3,900
| -17% | -$83.2K |
|
4302
ADT
ADT
$5.57B
| $416K | ﹤0.01% |
66,325
-172,434
| -72% | -$978K |
|
4303
PUT
Ares Capital
ARCC
$13.8B
| $416K | ﹤0.01% |
22,300
+8,600
| +63% | +$159K |
|
4304
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.4B
| $416K | ﹤0.01% |
7,136
+4,336
| +155% | +$250K |
|
4305
CALL
SSR Mining
SSRM
$6.03B
| $415K | ﹤0.01% |
28,600
-16,800
| -37% | -$258K |
|
4306
PUT
VeriSign
VRSN
$26.7B
| $415K | ﹤0.01% |
2,200
+1,500
| +214% | +$308K |
|
4307
Alliance Resource Partners
ARLP
$3.24B
| $414K | ﹤0.01% |
25,843
-75
| -0.3% | -$1.23K |
|
|
CCXI
4308
DELISTED
ChemoCentryx, Inc.
CCXI
| $414K | ﹤0.01% |
61,183
-21,257
| -26% | -$160K |
|
4309
Icahn Enterprises
IEP
$4.93B
| $413K | ﹤0.01% |
6,433
+6,233
| +3,117% | +$443K |
|
4310
Prudential
PUK
$34.8B
| $413K | ﹤0.01% |
11,712
-1,588
| -12% | -$59K |
|
4311
ProShares Ultra Gold
UGL
$710M
| $413K | ﹤0.01% |
35,156
+23,764
| +209% | +$282K |
|
|
NBEV
4312
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
| $413K | ﹤0.01% |
149,572
-9,659
| -6% | -$34.1K |
|
4313
PUT
Raymond James Financial
RJF
$34.7B
| $412K | ﹤0.01% |
7,500
-59,250
| -89% | -$3.22M |
|
4314
CALL
Silicon Laboratories
SLAB
$7.2B
| $412K | ﹤0.01% |
3,700
-500
| -12% | -$54.1K |
|
4315
CALL
Darling Ingredients
DAR
$9.34B
| $411K | ﹤0.01% |
21,500
+19,000
| +760% | +$371K |
|
4316
Central Garden & Pet Co
CENT
$2.76B
| $410K | ﹤0.01% |
17,531
+2,442
| +16% | +$52.9K |
|
|
BID
4317
PUT
DELISTED
Sotheby's
BID
| $410K | ﹤0.01% |
7,200
-3,500
| -33% | -$203K |
|
4318
Cerus
CERS
$455M
| $409K | ﹤0.01% |
79,418
-18,936
| -19% | -$102K |
|
4319
Hawkins
HWKN
$2.83B
| $409K | ﹤0.01% |
19,236
-3,194
| -14% | -$70K |
|
4320
Spectrum Brands
SPB
$2.12B
| $409K | ﹤0.01% |
7,757
-1,374
| -15% | -$71.7K |
|
4321
Dell
DELL
$310B
| $407K | ﹤0.01% |
15,514
-419,582
| -96% | -$11.1M |
|
4322
CALL
Nasdaq
NDAQ
$53.1B
| $407K | ﹤0.01% |
12,300
+11,400
| +1,267% | +$379K |
|
|
CHUY
4323
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $407K | ﹤0.01% |
16,386
-2,884
| -15% | -$69.7K |
|
|
MNRL
4324
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $407K | ﹤0.01% |
20,478
+3,248
| +19% | +$66.9K |
|
4325
PUT
Worthington Enterprises
WOR
$2.89B
| $404K | ﹤0.01% |
+18,166
| New | +$421K |
|
Similar funds
Barclays's Q3 2019 Portfolio in Review
As of Q3 2019, Barclays held 7,551 positions worth $160B, down 2.1% from $163B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays's Q3 2019 filing shows 501 new, 2,626 increased, 3,452 reduced and 568 closed positions. Its largest new stake was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $978M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2019 buy was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M.
- Barclays added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019, an estimated $629M increase.
- Barclays's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $978M.
- Barclays fully exited Anadarko Petroleum in Q3 2019, selling an estimated $309M.
- Barclays's ten largest holdings make up 28% of its $160B portfolio in Q3 2019.
- Barclays opened 501 new positions and closed 568 in Q3 2019.
- Barclays's portfolio value fell 2.1% quarter-over-quarter to $160B.
Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.